210 related articles for article (PubMed ID: 10735422)
1. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.
Ouriel K; Gray B; Clair DG; Olin J
J Vasc Interv Radiol; 2000 Mar; 11(3):295-8. PubMed ID: 10735422
[TBL] [Abstract][Full Text] [Related]
2. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
[TBL] [Abstract][Full Text] [Related]
3. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.
Ouriel K; Veith FJ; Sasahara AA
N Engl J Med; 1998 Apr; 338(16):1105-11. PubMed ID: 9545358
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic outcomes in thrombolytic treatment of peripheral arterial occlusive disease and deep venous thrombosis.
Ouriel K; Kaul AF; Leonard MC
J Vasc Surg; 2004 Nov; 40(5):971-7. PubMed ID: 15557913
[TBL] [Abstract][Full Text] [Related]
5. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.
Ann Surg; 1994 Sep; 220(3):251-66; discussion 266-8. PubMed ID: 8092895
[TBL] [Abstract][Full Text] [Related]
6. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions.
Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP
J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684
[TBL] [Abstract][Full Text] [Related]
7. Weight-based rt-PA thrombolysis protocol for acute native arterial and bypass graft occlusions.
Arepally A; Hofmann LV; Kim HS; Geschwind JF; Kirkwood S; Oechsle D; Perler B
J Vasc Interv Radiol; 2002 Jan; 13(1):45-50. PubMed ID: 11788694
[TBL] [Abstract][Full Text] [Related]
8. Catheter-Directed Thrombolysis With a Continuous Infusion of Low-Dose Alteplase for Subacute Proximal Venous Thrombosis: Efficacy and Safety Compared to Urokinase.
Gong M; He X; Song J; Zhao B; Shi W; Chen G; Gu J
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1333-1339. PubMed ID: 29768935
[TBL] [Abstract][Full Text] [Related]
9. Safety of thrombolytic therapy with urokinase or recombinant tissue plasminogen activator for peripheral arterial occlusion: a comprehensive compilation of published work.
Ouriel K; Kandarpa K
J Endovasc Ther; 2004 Aug; 11(4):436-46. PubMed ID: 15298504
[TBL] [Abstract][Full Text] [Related]
10. Bleeding complications associated with the use of rt-PA versus r-PA for peripheral arterial and venous thromboembolic occlusions.
McNamara TO; Dong P; Chen J; Quinn B; Gomes A; Goodwin S; Aban K
Tech Vasc Interv Radiol; 2001 Jun; 4(2):92-8. PubMed ID: 11981794
[TBL] [Abstract][Full Text] [Related]
11. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.
Meyerovitz MF; Goldhaber SZ; Reagan K; Polak JF; Kandarpa K; Grassi CJ; Donovan BC; Bettmann MA; Harrington DP
Radiology; 1990 Apr; 175(1):75-8. PubMed ID: 2107563
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic agents for peripheral arterial occlusion.
Robertson I; Kessel DO; Berridge DC
Cochrane Database Syst Rev; 2010 Mar; (3):CD001099. PubMed ID: 20238313
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic agents for peripheral arterial occlusion.
Robertson I; Kessel DO; Berridge DC
Cochrane Database Syst Rev; 2013 Dec; (12):CD001099. PubMed ID: 24357258
[TBL] [Abstract][Full Text] [Related]
15. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D
J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications.
Swischuk JL; Fox PF; Young K; Hussain S; Smouse B; Castañeda F; Brady TM
J Vasc Interv Radiol; 2001 Apr; 12(4):423-30. PubMed ID: 11287527
[TBL] [Abstract][Full Text] [Related]
17. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity.
Weaver FA; Comerota AJ; Youngblood M; Froehlich J; Hosking JD; Papanicolaou G
J Vasc Surg; 1996 Oct; 24(4):513-21; discussion 521-3. PubMed ID: 8911400
[TBL] [Abstract][Full Text] [Related]
18. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions.
Yoon HC; Miller FJ
AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686
[TBL] [Abstract][Full Text] [Related]
19. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
[TBL] [Abstract][Full Text] [Related]
20. Comparison of streptokinase and urokinase in local thrombolysis of peripheral arterial occlusions for lower limb salvage.
Dubé M; Soulez G; Thérasse E; Cartier P; Blair JF; Roy P; Robillard P; Bruneau L; Van Nguyen P; Cusson JR
J Vasc Interv Radiol; 1996; 7(4):587-93. PubMed ID: 8855542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
